Mechanistically, F. nucleatum activates STING signaling, leading to PD‐L1 upregulation and recruitment of interferon (IFN)‐γ+ CD8+ tumor‐infiltrating lymphocytes, which augment tumor sensitivity to PD‐L1 blockade and improve survival outcomes [76]. The gene discussed is CD8A; the disease is neoplasm.